Allegro Licenses Lung Cancer Testing IP from Boston University, University of Utah Foundation
June 29, 2011
Allegro Licenses Lung Cancer Testing IP from Boston University, University of Utah Foundation
The IP licensed by Allegro relates to a gene expression-based platform that detects common molecular responses that occur throughout the respiratory tract in current and former smokers with lung cancer.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.